Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...

Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention ...

CHICAGO (AP) -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it ...

Please provide your email address to receive an email when new articles are posted on . Patients with metformin-uncontrolled type 2 diabetes taking insulin and pioglitazone had greater risk for ...

The US Supreme Court cleared the way for a multibillion-dollar racketeering lawsuit that accuses Takeda Pharmaceutical Co. and Eli Lilly & Co. of marketing the Actos diabetes drug without disclosing ...

WASHINGTON, March 9 (Reuters) - Women taking Takeda Pharmaceutical Co. Ltd.'s. <4502.T> pioglitazone drug for diabetes reported more fractures than those taking a placebo or another drug in clinical ...

TOKYO, Nov 6 (Reuters) - Takeda Pharmaceutical Co. Ltd. <4502.T>, Japan's largest drug maker, lifted its annual outlook on Monday to above expectations after booking a 15 percent rise in first-half ...